Source:
The TimesIdentical twin sisters have led British scientists to a breakthrough in leukaemia research that promises more effective therapies with fewer harmful side-effects.
By comparing Olivia Murphy, 4, who is in remission from acute lymphoblastic leukaemia, and her healthy sister, Isabella, researchers have traced the tumour stem cells that drive the most common form of childhood cancer.
The discovery will enable doctors to screen young leukaemia patients to establish the severity of their illness and spare some the harrowing side effects of aggressive chemotherapy.
.........
The twins have been crucial to the new research, as they are genetically identical but one has developed cancer whereas the other has not. The scientists found that the girls’ blood contains genetically abnormal cells known as pre-leukaemic cells. These were formed by a mutation known as translocation, in which two genes fuse to create an abnormal new one. This random event happened in a single cell in one of the twins — it is impossible to tell which one — while they were still in the womb. As the twins shared a placenta, the original mutant’s daughter cells populated the blood of both sisters.
Read more:
http://www.timesonline.co.uk/tol/news/uk/science/article3207141.ece